Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15


Treatment of Post-Traumatic Stress Disorders with the Alpha-1 Adrenergic Antagonist Prazosin.

Simon PY, Rousseau PF.

Can J Psychiatry. 2017 Mar;62(3):186-198. doi: 10.1177/0706743716659275. Epub 2016 Jul 19.


Role of quetiapine beyond its clinical efficacy in bipolar disorder: From neuroprotection to the treatment of psychiatric disorders (Review).

Soeiro-DE-Souza MG, Dias VV, Missio G, Balanzá-Martinez V, Valiengo L, Carvalho AF, Moreno RA.

Exp Ther Med. 2015 Mar;9(3):643-652. Epub 2015 Jan 23.


Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease.

Wyrofsky R, McGonigle P, Van Bockstaele EJ.

Expert Opin Drug Discov. 2015 Jan;10(1):17-36. doi: 10.1517/17460441.2014.966680. Epub 2014 Dec 9. Review.


Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Katzman MA, Bleau P, Blier P, Chokka P, Kjernisted K, Van Ameringen M; Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University., Antony MM, Bouchard S, Brunet A, Flament M, Grigoriadis S, Mendlowitz S, O'Connor K, Rabheru K, Richter PM, Robichaud M, Walker JR.

BMC Psychiatry. 2014;14 Suppl 1:S1. doi: 10.1186/1471-244X-14-S1-S1. Epub 2014 Jul 2. Review.


Sleep disturbances and PTSD: a perpetual circle?

van Liempt S.

Eur J Psychotraumatol. 2012;3. doi: 10.3402/ejpt.v3i0.19142. Epub 2012 Oct 3.


Prazosin for the treatment of nightmares related to posttraumatic stress disorder: a review of the literature.

Hudson SM, Whiteside TE, Lorenz RA, Wargo KA.

Prim Care Companion CNS Disord. 2012;14(2). pii: PCC.11r01222. doi: 10.4088/PCC.11r01222. Epub 2012 Mar 22.


Treatment of nightmares with prazosin: a systematic review.

Kung S, Espinel Z, Lapid MI.

Mayo Clin Proc. 2012 Sep;87(9):890-900. doi: 10.1016/j.mayocp.2012.05.015. Epub 2012 Aug 9. Review.


Targeting memory processes with drugs to prevent or cure PTSD.

Cain CK, Maynard GD, Kehne JH.

Expert Opin Investig Drugs. 2012 Sep;21(9):1323-50. doi: 10.1517/13543784.2012.704020. Epub 2012 Jul 27. Review.


Stress-induced sensitization of cortical adrenergic receptors following a history of cannabinoid exposure.

Reyes BA, Szot P, Sikkema C, Cathel AM, Kirby LG, Van Bockstaele EJ.

Exp Neurol. 2012 Aug;236(2):327-35. doi: 10.1016/j.expneurol.2012.05.016. Epub 2012 Jun 4.


Noradrenergic modulation of wakefulness/arousal.

Berridge CW, Schmeichel BE, España RA.

Sleep Med Rev. 2012 Apr;16(2):187-97. doi: 10.1016/j.smrv.2011.12.003. Epub 2012 Jan 31. Review.


Pharmacological treatment of PTSD - established and new approaches.

Steckler T, Risbrough V.

Neuropharmacology. 2012 Feb;62(2):617-27. doi: 10.1016/j.neuropharm.2011.06.012. Epub 2011 Jun 29. Review.


Sleep neurobiology from a clinical perspective.

España RA, Scammell TE.

Sleep. 2011 Jul 1;34(7):845-58. doi: 10.5665/SLEEP.1112. Review.


Treating nightmares and insomnia in posttraumatic stress disorder: a review of current evidence.

Nappi CM, Drummond SP, Hall JM.

Neuropharmacology. 2012 Feb;62(2):576-85. doi: 10.1016/j.neuropharm.2011.02.029. Epub 2011 Mar 17. Review.


Effect of prazosin and guanfacine on stress-induced reinstatement of alcohol and food seeking in rats.

Lê AD, Funk D, Juzytsch W, Coen K, Navarre BM, Cifani C, Shaham Y.

Psychopharmacology (Berl). 2011 Nov;218(1):89-99. doi: 10.1007/s00213-011-2178-7. Epub 2011 Feb 12.

Supplemental Content

Support Center